BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25239422)

  • 101. Lung Cancer in Rwanda.
    Niyibizi BA; Muhizi E; Ndoli DA; Rukundo I; Muvunyi TZ; Musoni M; Dukundane D; Rudakemwa E; Rubagumya F; Van Christ Manirakiza A
    J Thorac Oncol; 2022 Sep; 17(9):1074-1077. PubMed ID: 36031287
    [No Abstract]   [Full Text] [Related]  

  • 102. Implementation and Validation of Telepathology Triage at Cancer Referral Center in Rural Rwanda.
    Mpunga T; Hedt-Gauthier BL; Tapela N; Nshimiyimana I; Muvugabigwi G; Pritchett N; Greenberg L; Benewe O; Shulman DS; Pepoon JR; Shulman LN; Milner DA
    J Glob Oncol; 2016 Apr; 2(2):76-82. PubMed ID: 28717686
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda.
    Rubagumya F; Wilson B; Manirakiza A; Mutabazi E; A Ndoli D; Rudakemwa E; Chamberlin MD; Hopman WM; Booth CM
    Oncologist; 2024 Mar; 29(3):e345-e350. PubMed ID: 37897406
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert
    Erfani P; Gaga E; Hakizimana E; Kayitare E; Mugunga JC; Shyirambere C; Milner DA; Shulman LN; Ruhangaza D; Fadelu T
    Bull World Health Organ; 2023 Jan; 101(1):10-19. PubMed ID: 36593782
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The role of telepathology in improving cancer diagnostic and research capacity in sub-Saharan Africa.
    Razzano D; Puranam K; Tomoka T; Fedoriw Y
    Front Med (Lausanne); 2022; 9():978245. PubMed ID: 36325383
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Evaluating urban-rural access to pathology and laboratory medicine services in Tanzania.
    Iyer HS; Wolf NG; Flanigan JS; Castro MC; Schroeder LF; Fleming K; Vuhahula E; Massambu C
    Health Policy Plan; 2021 Aug; 36(7):1116-1128. PubMed ID: 34212191
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Strengthening Pathology Capacity to Deliver Quality Cancer Care in Cities in LMICs.
    Frech S; Bravo LE; Rodriguez I; Pomata A; Aung KT; Soe AN; Hornburg B; Guarner J; Brock J; Camacho R; Milner D
    JCO Glob Oncol; 2021 Jun; 7():917-924. PubMed ID: 34129368
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Psychometric Properties of the Beck Depression Inventory (BDI-II) in Cancer Patients: Cancer Patients from Butaro Ambulatory Cancer Center, Rwanda.
    Biracyaza E; Habimana S; Rusengamihigo D
    Psychol Res Behav Manag; 2021; 14():665-674. PubMed ID: 34104012
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia.
    Mumba JM; Kasonka L; Owiti OB; Andrew J; Lubeya MK; Lukama L; Kasempa C; Msadabwe SC; Kalinda C
    Gynecol Oncol Rep; 2021 Aug; 37():100784. PubMed ID: 34095422
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Laboratory Turnaround Time of Surgical Biopsies at a Histopathology Service in Nigeria.
    Emmanuel I; Abaniwo S; Nzekwe P; Richard SK; Abobarin O; Longwap A; Joseph A
    Niger Med J; 2020; 61(4):180-183. PubMed ID: 33284886
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Geospatial evaluation of trade-offs between equity in physical access to healthcare and health systems efficiency.
    Iyer HS; Flanigan J; Wolf NG; Schroeder LF; Horton S; Castro MC; Rebbeck TR
    BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33087394
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Interventions Addressing Barriers to Delayed Cancer Diagnosis in Low- and Middle-Income Countries: A Systematic Review.
    Qu LG; Brand NR; Chao A; Ilbawi AM
    Oncologist; 2020 Sep; 25(9):e1382-e1395. PubMed ID: 32125732
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda.
    Park PH; Davey S; Fehr AE; Butonzi J; Shyirambere C; Hategekimana V; Bigirimana JB; Borg R; Uwizeye R; Tapela N; Shulman LN; Randall T; Mpanumusingo E; Mpunga T
    J Glob Oncol; 2018 Dec; 4():1-11. PubMed ID: 30582433
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Improving Health and Cancer Services in Low-Resource Countries to Attain the Sustainable Development Goals Target 3.4 for Noncommunicable Diseases.
    Morgan GW; Foster K; Healy B; Opie C; Huynh V
    J Glob Oncol; 2018 Dec; 4():1-11. PubMed ID: 30582432
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Task Sharing and Shifting to Provide Pathology Diagnostic Services: The Kenya Fine-Needle Aspiration Biopsy Cytology and Bone Marrow Aspiration and Trephine Biopsy Training Program.
    Sayed S; Field A; Rajab J; Mutuiri A; Githanga J; Mungania M; Okinda N; Moloo Z; Abdillah A; Ayara B; Chesori E; Muthua J; Obosy L; Massawa T; Obiero O; Kagotho E; Shikuku PK; Gachii AK; Migide E; Muninzwa D; Dawsey SM; Muchiri L
    J Glob Oncol; 2018 Nov; 4():1-11. PubMed ID: 30398948
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Impact of delayed care on surgical management of patients with gastric cancer in a low-resource setting.
    Martin AN; Silverstein A; Ssebuufu R; Lule J; Mugenzi P; Fehr A; Mpunga T; Shulman LN; Park PH; Costas-Chavarri A
    J Surg Oncol; 2018 Dec; 118(8):1237-1242. PubMed ID: 30380140
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Cost of Providing Quality Cancer Care at the Butaro Cancer Center of Excellence in Rwanda.
    Neal C; Rusangwa C; Borg R; Tapela N; Mugunga JC; Pritchett N; Shyirambere C; Ntakirutimana E; Park PH; Shulman LN; Mpunga T
    J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241219
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Breast Cancer Pathology Turnaround Time in Botswana.
    Martei YM; Narasimhamurthy M; Prabhakar P; Hutson J; Setlhako DI; Chiyapo S; Ramogola-Masire D; Makozhombwe I; Feldman M; Kayembe MKA; Grover S
    J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241141
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Decreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda.
    Muvugabigwi G; Nshimiyimana I; Greenberg L; Hakizimana E; Ruhangaza D; Benewe O; Bhai K; Pepoon JR; Fehr AE; Park PH; Butonzi J; Shyirambere C; Manirakiza A; Rusangwa C; Milner D; Mpunga T; Shulman LN
    J Glob Oncol; 2018 Sep; 4():1-6. PubMed ID: 30241136
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Establishing Cancer Treatment Programs in Resource-Limited Settings: Lessons Learned From Guatemala, Rwanda, and Vietnam.
    Wagner CM; Antillón F; Uwinkindi F; Thuan TV; Luna-Fineman S; Anh PT; Huong TT; Valverde P; Eagan A; Binh PV; Quang TN; Johnson S; Binagwaho A; Torode J
    J Glob Oncol; 2018 Jul; 4():1-14. PubMed ID: 30085895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.